Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc. annual/quarterly operating income history and growth rate from 2022 to 2023. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Unicycive Therapeutics Inc. operating income for the quarter ending March 31, 2023 was -4.2 M.
• Unicycive Therapeutics Inc. annual operating income for 2023 was -20.8 M, a 15.08% increase from 2022.
• Unicycive Therapeutics Inc. annual operating income for 2022 was -18.1 M.